Massachusetts H5382 aims to eliminate the use of DEHP in medical devices by 2035.
Massachusetts H5382 mandates the removal of intentionally added Di(2-ethylhexyl) phthalate (DEHP) from intravenous solution containers and tubing by 2035. The bill also prohibits the replacement of DEHP with other ortho-phthalates in medical devices. It requires manufacturers to notify customers and post notices by 2028 if they cannot meet the deadlines. Exemptions apply to certain blood collection and storage bags and apheresis containers. The bill aims to improve public health by reducing exposure to harmful chemicals in medical devices.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.